TLR agonists that induce IFN-β abrogate resident macrophage suppression of T cells

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4545-4553

  Hamilton, Melisa J ^a   Antignano, Frann ^a   Rossum, Anna Von ^a   Boucher, Jean Luc ^b   Bennewith, Kevin L ^c   Krystal, Gerald ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR AGONIST; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; AUTOCRINE EFFECT; CELL EXPANSION; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MACROPHAGE; MICROORGANISM; MOUSE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL SEPARATION; DRUG POTENTIATION; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; IMMUNE TOLERANCE; INTERFERON-BETA; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 78049499942     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002045     Document Type: Article

References (45)

1. Bettini, M., and D. A. Vignali. 2009. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr. Opin. Immunol. 21:612-618.
2. Munn, D. H., and A. L. Mellor. 2003. Macrophages and the regulation of selfreactive T cells. Curr. Pharm. Des. 9:257-264.
3. Brem-Exner, B. G., C. Sattler, J. A. Hutchinson, G. E. Koehl, K. Kronenberg, S. Farkas, S. Inoue, C. Blank, S. J. Knechtle, H. J. Schlitt, et al. 2008. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J. Immunol. 180:335-349.
4. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32:593-604.
5. Hoves, S., S. W. Krause, C. Schütz, D. Halbritter, J. Schölmerich, H. Herfarth, and M. Fleck. 2006. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J. Immunol. 177:2691-2698.
6. Allison, A. C. 1978. Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol. Rev. 40:3-27.
7. Metzger, Z., J. T. Hoffeld, and J. J. Oppenheim. 1980. Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol. 124:983-988.
8. Albina, J. E., J. A. Abate, and W. L. Henry, Jr. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogenstimulated T cell proliferation. Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:144-148.
9. Strickland, D., U. R. Kees, and P. G. Holt. 1996. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 87:250-258.
10. Munn, D. H., E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1363-1372.
11. Kung, J. T., S. B. Brooks, J. P. Jakway, L. L. Leonard, and D. W. Talmage. 1977. Suppression of in vitro cytotoxic response by macrophages due to induced arginase. J. Exp. Med. 146:665-672.
12. Rodriguez, P. C., A. H. Zea, J. DeSalvo, K. S. Culotta, J. Zabaleta, D. G. Quiceno, J. B. Ochoa, and A. C. Ochoa. 2003. L-arginine consumption by macrophages modulates the expression of CD3 ζ chain in T lymphocytes. J. Immunol. 171:1232-1239.
13. Smythies, L. E., M. Sellers, R. H. Clements, M. Mosteller-Barnum, G. Meng, W. H. Benjamin, J. M. Orenstein, and P. D. Smith. 2005. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115:66-75.
14. Cox, G. W., G. Melillo, U. Chattopadhyay, D. Mullet, R. H. Fertel, and L. Varesio. 1992. Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-γ plus IL-2-induced murine macrophage tumoricidal activity. J. Immunol. 149:3290-3296.
15. Deng, W., B. Thiel, C. S. Tannenbaum, T. A. Hamilton, and D. J. Stuehr. 1993. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol. 151:322-329.
16. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
17. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
18. Damen, J. E., H. Wakao, A. Miyajima, J. Krosl, R. K. Humphries, R. L. Cutler, and G. Krystal. 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:5557-5568.
19. Kleinbongard, P., T. Rassaf, A. Dejam, S. Kerber, and M. Kelm. 2002. Griess method for nitrite measurement of aqueous and protein-containing samples. Methods Enzymol. 359:158-168.
20. Sly, L. M., M. J. Hamilton, E. Kuroda, V. W. Ho, F. L. Antignano, S. L. Omeis, C. J. van Netten-Thomas, D. Wong, H. K. Brugger, O. Williams, et al. 2009. SHIP prevents lipopolysaccharide from triggering an antiviral response in mice. Blood 113:2945-2954.
21. Bingisser, R. M., P. A. Tilbrook, P. G. Holt, and U. R. Kees. 1998. Macrophagederived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J. Immunol. 160:5729-5734.
22. Kuroda, E., V. Ho, J. Ruschmann, F. Antignano, M. Hamilton, M. J. Rauh, A. Antov, R. A. Flavell, L. M. Sly, and G. Krystal. 2009. SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils. J. Immunol. 183:3652-3660.
23. Mace, E. M., S. J. Monkley, D. R. Critchley, and F. Takei. 2009. A dual role for talin in NK cell cytotoxicity: activation of LFA-1-mediated cell adhesion and polarization of NK cells. J. Immunol. 182:948-956.
24. Alcón, V. L., C. Luther, D. Balce, and F. Takei. 2009. B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-γ production but not cytotoxicity. Eur. J. Immunol. 39:826-832.
25. Sly, L. M., J. Kalesnikoff, V. Lam, D. Wong, C. Song, S. Omeis, K. Chan, C. W. K. Lee, R. P. Siraganian, J. Rivera, and G. Krystal. 2008. IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species. J. Immunol. 181:3850-3860.
26. Rauh, M. J., V. Ho, C. Pereira, A. Sham, L. M. Sly, V. Lam, L. Huxham, A. I. Minchinton, A. Mui, and G. Krystal. 2005. SHIP represses the generation of alternatively activated macrophages. Immunity 23:361-374.
27. Levings, M. K., and M. G. Roncarolo. 2000. T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J. Allergy Clin. Immunol. 106: S109-S112.
28. von Bergwelt-Baildon, M. S., A. Popov, T. Saric, J. Chemnitz, S. Classen, M. S. Stoffel, F. Fiore, U. Roth, M. Beyer, S. Debey, et al. 2006. CD25 and indoleamine 2, 3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 108:228-237.
29. Rodriguez, P. C., A. H. Zea, K. S. Culotta, J. Zabaleta, J. B. Ochoa, and A. C. Ochoa. 2002. Regulation of T cell receptor CD3ζ chain expression by L-arginine. J. Biol. Chem. 277:21123-21129.
30. Gandhi, R., D. E. Anderson, and H. L. Weiner. 2007. Cutting edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-β-dependent manner. J. Immunol. 178:4017-4021.
31. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916.
32. Lorsbach, R. B., and S. W. Russell. 1992. A specific sequence of stimulation is required to induce synthesis of the antimicrobial molecule nitric oxide by mouse macrophages. Infect. Immun. 60:2133-2135.
33. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818.
34. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
35. Hagemann, T., T. Lawrence, I. McNeish, K. A. Charles, H. Kulbe, R. G. Thompson, S. C. Robinson, and F. R. Balkwill. 2008. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J. Exp. Med. 205:1261-1268.
36. Gough, D. J., N. L. Messina, L. Hii, J. A. Gould, K. Sabapathy, A. P. Robertson, J. A. Trapani, D. E. Levy, P. J. Hertzog, C. J. Clarke, and R. W. Johnstone. 2010. Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol. 8: e1000361.
37. Ling, P. D., M. K. Warren, and S. N. Vogel. 1985. Antagonistic effect of interferon-β on the interferon-γ-induced expression of Ia antigen in murine macrophages. J. Immunol. 135:1857-1863.
38. Inaba, K., M. Kitaura, T. Kato, Y. Watanabe, Y. Kawade, and S. Muramatsu. 1986. Contrasting effect of α/β-and γ-interferons on expression of macrophage Ia antigens. J. Exp. Med. 163:1030-1035. (Pubitemid 16082816)
39. Yoshida, R., H. W. Murray, and C. F. Nathan. 1988. Agonist and antagonist effects of interferon α and β on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon α or β. J. Exp. Med. 167:1171-1185.
40. Rayamajhi, M., J. Humann, K. Penheiter, K. Andreasen, and L. L. Lenz. 2010. Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ. J. Exp. Med. 207:327-337.
41. Martin, C. W., and I. F. Muir. 1990. The role of lymphocytes in wound healing. Br. J. Plast. Surg. 43:655-662.
42. Composto, G., D. Gonzalez, A. Bucknum, D. Silberman, J. Taylor, M. Kozlowski, T. Bloomfield, T. Bartlett, and J. Riggs. 2010. Peritoneal T lymphocyte regulation by macrophages. Immunobiology.
43. Taylor-Robinson, A. W., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, J. Padron, and R. S. Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:980-984.
44. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
45. McKee, A. S., M. W. Munks, and P. Marrack. 2007. How do adjuvants work? Important considerations for new generation adjuvants. Immunity 27:687-690.